Author

Smruti Arjani

Observed name: S Arjani

Institution: AstraZeneca (Canada)

Observed institution: AstraZeneca (Canada)

OpenAlex ID: A5125520615

B29-17 Albuterol-budesonide Treatment for Acute Airway Obstruction Provides Enhanced Lung Function Improvement Compared to Albuterol in Mild Asthma Irrespective of Baseline Forced Expiratory Volume in One-second (FEV1)

2026 · R A Panettieri, B J Lipworth, et al. · American Journal of Respiratory and Critical Care Medicine

Albuterol-Budesonide Treatment in Acute Airway Obstruction Provides Enhanced Lung Function Improvement for Patients With Well-Controlled and Uncontrolled Mild Asthma

2026 · Autumn Burnette, Reynold Panettieri, et al. · Journal of Allergy and Clinical Immunology

Works count: 2

Citation count:

H-index:

I10-index: